Journal
HAEMATOLOGICA
Volume 93, Issue 6, Pages 951-952Publisher
FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.12557
Keywords
chemotherapy; rituximab; HBV; potential occult carrier; reactivation